|
Antibiotics revieweda
| |
|
• Carbapenems
|
37
|
|
• 3rd and 4th generation cephalosporins
|
17
|
|
• Piperacillin/tazobactam
|
32
|
|
• Vancomycin
|
16
|
|
• Others
|
14
|
|
Number of antimicrobial stewardship recommendations made:
|
28
|
|
• Discontinuation of antibiotic therapy (percentage of all recommendations)
|
12 (42.9%)
|
|
• De-escalation of antibiotic therapy (percentage of all recommendations)
|
5 (17.9%)
|
|
• Intravenous to enteral switch (percentage of all recommendations)
|
1 (3.6%)
|
|
• Escalation of antibiotic therapy (percentage of all recommendations)
|
1 (3.6%)
|
|
• Antibiotic dosing (percentage of all recommendations)
|
3 (10.7%)
|
|
• Othersb (percentage of all recommendations)
|
6 (21.4%)
|
|
Recommendation acceptance (percentage of all recommendations):
|
20 (71.4%)
|
|
• Discontinuation of antibiotic therapy (percentage of similar recommendations)
|
9 (75.0%)
|
|
• De-escalation of antibiotic therapy (percentage of similar recommendations)
|
3 (60.0%)
|
|
• Intravenous to enteral switch (percentage of similar recommendations)
|
0 (0%)
|
|
• Escalation of antibiotic therapy (percentage of similar recommendations)
|
1 (100%)
|
|
• Antibiotic dosing (percentage of similar recommendations)
|
3 (100%)
|
|
• Othersb (percentage of similar recommendations)
|
4 (66.7%)
|
|
Potential additional antimicrobial stewardship recommendations based on local guidelines [4] and/or clinical criteria:
| |
|
• Discontinuation of antimicrobial therapyc
|
3
|
|
• De-escalation of antibiotic therapyd
|
5
|
|
• Intravenous to enteral switch
|
3
|
